EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antidepressant Misuse in Esports: A Review of Pharmacology, Adverse Effects, Pharmacokinetics and Biomatrix‐Based Detection for Anti‐Doping Applications

Kassim Ali Salum, Shao-Hsin Hung iD, Meng-Tsang Hsieh, Mei-Chich Hsu iD, William Chih-Wei Chang iD

Drug Testing and Analysis · 2026-11 · 18 (11) · 1361-1373

DOI: 10.1002/dta.70131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Testing and Analysis, online erschienen am 11.08.2026. Verfasst von Kassim Ali Salum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan. Hauptthemen laut MEDLINE: Doping in Sports, Antidepressive Agents, Substance Abuse Detection, Performance-Enhancing Substances. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chi Mei Medical Center and Kaohsiung Medical University Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esports has undergone rapid expansion over the past two decades, bringing with it challenges analogous to those observed in traditional athletic domains, particularly the misuse of performance‐enhancing drugs (PEDs). Doping poses a dual threat to competitive integrity and player health, yet its manifestation in Esports remains insufficiently examined compared with conventional sports. This disparity has contributed to the under‐recognition of substance misuse in professional gaming and the emergence of associated health risks among players. A lack of awareness among tournament organisers and regulatory bodies has further impeded the establishment of comprehensive anti‐doping frameworks. To address this gap, the Esports Integrity Commission (ESIC) introduced a prohibited substances list tailored to the cognitive and psychological demands of Esports, acknowledging the limitations of the World Anti‐Doping Agency (WADA) framework in this context. Substances commonly implicated in Esports doping include nootropics and other cognitive enhancers that improve attention, reaction speed and mental stamina. While stimulants such as medications for attention‐deficit/hyperactivity disorder (ADHD) and energy drinks have been widely discussed, the non‐medical use of antidepressants remains underexplored and insufficiently regulated despite their inclusion on ESIC monitoring lists. This review provides a critical synthesis of the pharmacology, pharmacokinetics, adverse effects and analytical detection strategies for antidepressants relevant to Esports doping. A co‐citation analysis of 3756 references published between 2000 and 2025 was conducted to map the field's intellectual structure. Systematic screening identified 69 key studies that met predefined inclusion criteria and were analysed in detail.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsAntidepressive AgentsSubstance Abuse DetectionPerformance-Enhancing SubstancesHumansSports

Stichwörter der Autor:innen

Esports Integrity Commission (ESIC)World Anti‐Doping Agency (WADA)cognitive enhancementdopinggovernance

Substanzen

Antidepressive AgentsPerformance-Enhancing Substances

Autor:innen und Institutionen

  • Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan.
  • Department of Natural Science, The State University of Zanzibar, Zanzibar, Tanzania.
  • Department of Neurology, Chi Mei Medical Center, Tainan City, Taiwan.
  • School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan.
  • Department of Sports Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
  • School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan.

ORCID-Profile: Shao-Hsin Hung, Mei-Chich Hsu, William Chih-Wei Chang

Förderung

  • National Science and Technology Council
  • Chi Mei Medical Center and Kaohsiung Medical University Research Foundation

Zitieren

APA

Salum, K. A., Hung, S. H., Hsieh, M. T., Hsu, M. C., & Chang, W. C. (2026). Antidepressant Misuse in Esports: A Review of Pharmacology, Adverse Effects, Pharmacokinetics and Biomatrix‐Based Detection for Anti‐Doping Applications. Drug Testing and Analysis, 18(11), 1361-1373. https://doi.org/10.1002/dta.70131

Vancouver

Salum KA, Hung SH, Hsieh MT, Hsu MC, Chang WC. Antidepressant Misuse in Esports: A Review of Pharmacology, Adverse Effects, Pharmacokinetics and Biomatrix‐Based Detection for Anti‐Doping Applications. Drug Testing and Analysis. 2026;18(11):1361-1373. doi:10.1002/dta.70131

BibTeX
@article{Salum2026,
  author = {Salum, Kassim Ali and Hung, Shao-Hsin and Hsieh, Meng-Tsang and Hsu, Mei-Chich and Chang, William Chih-Wei},
  title = {Antidepressant Misuse in Esports: A Review of Pharmacology, Adverse Effects, Pharmacokinetics and Biomatrix‐Based Detection for Anti‐Doping Applications},
  journal = {Drug Testing and Analysis},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1361--1373},
  doi = {10.1002/dta.70131}
}
Kostenlos starten →